Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment

Abiraterone acetate (ABI) is associated not only with a significant survival advantage in both chemotherapy-naive and -treated patients with metastatic castration-resistant prostate cancer (mCRPC), but also with a delay in time to development of Skeletal Related Events and in radiological skeletal p...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Iuliani, Michele, Pantano, Francesco, Buttigliero, Consuelo, Fioramonti, Marco, Bertaglia, Valentina, Vincenzi, Bruno, Zoccoli, Alice, Ribelli, Giulia, Tucci, Marcello, Vignani, Francesca, Berruti, Alfredo, Scagliotti, Giorgio Vittorio, Tonini, Giuseppe, Santini, Daniele
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2015
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4494955/
https://ncbi.nlm.nih.gov/pubmed/25904051
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires